News
KSPHF
30.28
NaN%
--
UBS Initiates a Hold Rating on Kissei Pharmaceutical Co (KSPHF)
TipRanks · 12/14 13:55
Kissei Pharmaceutical Adjusts Dividend Payment Date
TipRanks · 12/01 07:04
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
TipRanks · 11/05 07:43
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
TipRanks · 11/04 10:22
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
TipRanks · 11/04 07:04
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
TipRanks · 10/27 18:45
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
TipRanks · 10/27 18:31
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
TipRanks · 10/27 17:05
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
TipRanks · 10/27 16:59
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
TipRanks · 10/27 16:51
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
TipRanks · 10/23 06:54
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
Barchart · 10/08 02:08
Kissei Pharmaceutical Completes Sale of Investment Securities
TipRanks · 09/25 06:54
Weekly Report: what happened at KSPHF last week (0908-0912)?
Weekly Report · 09/15 11:25
Weekly Report: what happened at KSPHF last week (0901-0905)?
Weekly Report · 09/08 11:28
Weekly Report: what happened at KSPHF last week (0825-0829)?
Weekly Report · 09/01 11:22
Weekly Report: what happened at KSPHF last week (0818-0822)?
Weekly Report · 08/25 11:35
Weekly Report: what happened at KSPHF last week (0811-0815)?
Weekly Report · 08/18 11:26
Weekly Report: what happened at KSPHF last week (0804-0808)?
Weekly Report · 08/11 11:34
More
Webull provides a variety of real-time KSPHF stock news. You can receive the latest news about Kissei Pharm through multiple platforms. This information may help you make smarter investment decisions.
About KSPHF
Kissei Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through four segments. The Pharmaceutical segment manufactures and sells prescription drugs, and also purchases and sells healthcare foods such as prescription drugs and foods for special medical purposes. The Goods Sales segment is engaged in the development, production and sale of noodles, the sale of various equipment, vehicles and fuel, as well as insurance agency business. The Information Services segment operates in three areas including system integration services, system resource services such as information-related equipment rental and network construction, and medical system development and sales. The Construction and Facility Maintenance segment provides comprehensive construction services ranging from building construction to the maintenance and management of equipment and facilities.